APOC1 anticorps (FITC)

N° du produit ABIN7454058

Détail du produit anti-APOC1 anticorps (FITC)

Antigène: APOC1 (Apolipoprotein C-I (APOC1))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp APOC1 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Fonction: Goat anti-Human Apo CI [F07] Antibody FITC Conjugated

Immunogène: Human Apolipoprotein CI

Clone: F07

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur APOC1

Antigène: APOC1 (Apolipoprotein C-I (APOC1))

Autre désignation: ApoCI (APOC1 Produits)

Synonymes: anticorps Apo-CIB, anticorps ApoC-IB, anticorps ALPCI, anticorps LRRG04, anticorps APOC1, anticorps apoc1, anticorps apolipoprotein C1, anticorps apolipoprotein C-I, anticorps Apolipoprotein C-I, anticorps APOC1, anticorps Apoc1, anticorps apoc1

Sujet: Background: ApoCI contains 57 amino acid residues and the m.w. is 6.6 kDa (Jackson et al., 1974). ApoCI has been found to activate LCAT (Liu and Subbaiah 1993). Apo CI is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. Apo CI is also an inhibitor of the plasma cholesteryl ester transfer protein and of fatty acid uptake into tissues (Shachter, 2001). This inhibition role can potentially regulate several lipase enzymes. (Poensgen, 1990, Conde-Knape et al., 2002, Berbee et al., 2005)

ID gène: 341

NCBI Accession: NP_001636

UniProt: P02654

Pathways: Apoptose